Daxor
DXR
7 hedge funds and large institutions have $867K invested in Daxor in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 3.52% → 3.52% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
13% less funds holding
Funds holding: 8 → 7 (-1)
16% less capital invested
Capital invested by funds: $1.03M → $867K (-$162K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$401 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.38K |
DXR Hedge Fund Activity: Q2 2017 in Review
7 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2017, worth a combined $867K — down 16% from $1.03M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $401. The largest seller was Renaissance Technologies, cutting an estimated $1.38K.
- 7 institutional investors held Daxor (DXR) as of Q2 2017, down from 8 in Q1 2017.
- Funds reported $867K of Daxor stock for Q2 2017, down 16% quarter-over-quarter.
- 0 funds opened new Daxor positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest Daxor buyer in Q2 2017 was Tower Research Capital (TRC), an estimated $401 added.
- The largest Daxor seller in Q2 2017 was Renaissance Technologies, an estimated $1.38K sold.
Based on aggregated 13F filings for Q2 2017.